Deutsche Bank
UROV

Deutsche Bank’s Urovant Sciences Ltd. UROV Stock Holding History

Deutsche Bank’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed – – 4598
2020
Q3 		$0 Buy
+3
New +$27 ﹤0.01% 4512
2020
Q2 		– Sell
-1
Closed – – 4568
2020
Q1 		$0 Sell
1
-1,530
-100% -$18.4K ﹤0.01% 5080
2019
Q4 		$23K Buy
+1,531
New +$16.6K ﹤0.01% 4264
2019
Q1 		– Sell
-3,390
Closed -$22K – 5541
2018
Q4 		$22K Buy
+3,390
New +$30.8K ﹤0.01% 4721

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
OCM
Orchard Capital Management Chicago, Illinois $95.9M AUM 45.49% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Deutsche Bank's UROV Position: Q4 2020 in Review

Deutsche Bank sold out of Urovant Sciences Ltd. (UROV) in Q4 2020, closing a stake of 3 shares.

Deutsche Bank first reported a position in UROV in Q4 2018 and held it in 4 quarters. The position peaked at $23K in Q4 2019. 41 funds tracked by Wall St. Rank hold UROV as of Q4 2020.

  • Deutsche Bank reported no remaining Urovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Deutsche Bank sold 3 Urovant Sciences Ltd. shares in Q4 2020.
  • Deutsche Bank first reported a position in Urovant Sciences Ltd. in Q4 2018 and held it in 4 quarters.
  • Deutsche Bank's Urovant Sciences Ltd. position peaked at $23K in Q4 2019.
  • 41 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.